We have recently shown that
penta-1,2,3,4,6-O-galloyl-beta-D-glucose (
PGG), a naturally occurring hydrolyzable
gallotannin, inhibited the in vivo growth of human
androgen-independent p53-mutant DU145
prostate cancer (PCa) xenograft in athymic nude mice without adverse effect on their
body weight. We have also shown that
PGG induced
caspase-mediated apoptosis in the DU145 cells and the
androgen-dependent human p53-wild-type LNCaP cells. Here, we investigated the cell cycle effects of
PGG in these and other PCa cells. Our data show that treatment with subapoptotic doses of
PGG induced S-arrest, whereas higher doses of
PGG induced not only S-arrest but also G(1) arrest. We show, for the first time, that irrespective of the p53 functional status of the PCa cell lines,
PGG exerted a rapid (within 2 h) and potent inhibition (inhibitory concentration by 50% approximately 6 microM) of
5-bromo-2'-deoxyuridine incorporation into S phase cells. In isolated nuclei,
PGG inhibited
DNA replicative synthesis with superior efficacy than a known
DNA polymerase alpha inhibitor, aphidocolin. In addition to the S-arrest action, we have found a close association of downregulation of
cyclin D1 with G(1) arrest induced by
PGG. Overexpressing this G(1)
cyclin abolished G(1) arrest, but hastened the S-arrest induction by
PGG. Together, our data indicate that
PGG induced PCa S-arrest probably through
DNA replicative blockage and induced G(1) arrest via
cyclin D1 downregulation to contribute to anticancer activity. Our data raise the hypothesis that
PGG may be a novel inhibitor of
DNA polymerases.